Delivery Order SPE2DB24D1021-SPE2DB24FEUKJ

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,422.84 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has a period of performance through July 3, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This $71,221.86 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $13,592.72, is a delivery order contract for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of March 13,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $98,244.78 Firm Fixed Price Delivery Order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty pharmaceutical product. The contract has an ultimate completion date of July 7, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order valued at $36,205.71, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a prescription medication, with a completion date of May 30, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a $34,963.53 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, to support DLA's medical supply requirements. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,283.32 firm fixed-price contract is for the delivery of the medication BIKTARVY 50-200-25 MG TABLET UU 30S. The contract has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $42,465.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product, with a completion date of September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,055.16 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The contract has an ultimate completion date of February 25, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,355.45, is for the provision of BIKTARVY 50-200-25 MG TABLET medical supplies. The contract is a firm fixed-price delivery order with a period of performance through March 12, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FEUKJ
    Delivery Order

This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corporation's Corporate Office division. The $36,099.83 contract is for the supply of BIKTARVY 50-200-25 MG TABLET pharmaceutical products. The contract has a performance period through September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including critical care supplies and pharmaceuticals, in support of military treatment facilities, veterans' healthcare, and other government healthcare programs. This particular contract award is not designated as a set-aside.

Generated 12/27/24, 9:12 AM